Abivax to present at the 39th Annual J.P. Morgan Healthcare Conference ahead of major clinical miles
Search jobs 21-Dec-2020 DGAP-News: ABIVAX / Key word(s): Conference 21.12.2020 / 18:30 Abivax to present at the 39 ahead of major clinical milestones PARIS, December 21, 2020 - 6:30 p.m. (CET) - Abivax (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory diseases, viral diseases and cancer, today announced that Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax, will present at the 39 th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021 at 10:00 am to 1...